标题
Current views on the potential for development of a HIV vaccine
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 17, Issue 3, Pages 295-303
出版商
Informa UK Limited
发表日期
2017-01-18
DOI
10.1080/14712598.2017.1282457
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques
- (2016) Brian Moldt et al. AIDS
- VRC01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-BLT mice
- (2016) Ming Sun et al. ARCHIVES OF VIROLOGY
- Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
- (2016) Bryan Briney et al. CELL
- Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
- (2016) Amelia Escolano et al. CELL
- Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
- (2016) Ming Tian et al. CELL
- Lower Viral Loads and Slower CD4+T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02
- (2016) Ellen M. Leitman et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
- (2016) Johannes F. Scheid et al. NATURE
- A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
- (2016) Rajeev Gautam et al. NATURE
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
- (2016) M Gordon Joyce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
- (2016) D. Sok et al. SCIENCE
- Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E
- (2016) S. G. Hansen et al. SCIENCE
- Induction of neutralizing antibodies in rhesus macaques using V3 mimotope peptides
- (2016) Ann J. Hessell et al. VACCINE
- Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
- (2016) Andrew T. McGuire et al. Nature Communications
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
- (2016) M Gordon Joyce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
- (2015) Steven W. de Taeye et al. CELL
- Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
- (2015) Pia Dosenovic et al. CELL
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
- (2015) Amy W. Chung et al. CELL
- Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
- (2015) Tongqing Zhou et al. CELL
- Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
- (2015) Raiees Andrabi et al. IMMUNITY
- Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env
- (2015) Ivelin S. Georgiev et al. JOURNAL OF VIROLOGY
- COMPASS identifies T-cell subsets correlated with clinical outcomes
- (2015) Lin Lin et al. NATURE BIOTECHNOLOGY
- Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
- (2015) Jeanne M. Marrazzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
- (2015) J. G. Jardine et al. SCIENCE
- HIV-1 neutralizing antibodies induced by native-like envelope trimers
- (2015) R. W. Sanders et al. SCIENCE
- Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
- (2015) D. H. Barouch et al. SCIENCE
- Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
- (2015) Shailendra Kumar Sharma et al. Cell Reports
- Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men
- (2015) Zoe Moodie et al. PLoS One
- Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials
- (2015) Yunda Huang et al. PLoS One
- HVTN 097: Evaluation of the RV144 Vaccine Regimen in HIV Uninfected South African Adults
- (2014) Glenda E. Gray et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
- (2014) Feng Gao et al. CELL
- Progress in HIV-1 vaccine development
- (2014) Barton F. Haynes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
- (2014) Paul A. Goepfert et al. JOURNAL OF INFECTIOUS DISEASES
- Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
- (2014) Alejandro B Balazs et al. NATURE MEDICINE
- Altered Response Hierarchy and Increased T-Cell Breadth upon HIV-1 Conserved Element DNA Vaccination in Macaques
- (2014) Viraj Kulkarni et al. PLoS One
- HIV-1 Conserved Elements p24CE DNA Vaccine Induces Humoral Immune Responses with Broad Epitope Recognition in Macaques
- (2014) Viraj Kulkarni et al. PLoS One
- Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
- (2014) Anila Yasmeen et al. Retrovirology
- Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies
- (2014) A. T. McGuire et al. SCIENCE
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
- (2013) Peter Hraber et al. AIDS
- HIV-1 neutralizing antibodies: understanding nature's pathways
- (2013) John R. Mascola et al. IMMUNOLOGICAL REVIEWS
- Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
- (2013) Andrew T. McGuire et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection
- (2013) Holly Janes et al. JOURNAL OF INFECTIOUS DISEASES
- Emergence of gp120 V3 Variants Confers Neutralization Resistance in an R5 Simian-Human Immunodeficiency Virus-Infected Macaque Elite Neutralizer That Targets the N332 Glycan of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein
- (2013) R. Sadjadpour et al. JOURNAL OF VIROLOGY
- Neutralizing IgG at the Portal of Infection Mediates Protection against Vaginal Simian/Human Immunodeficiency Virus Challenge
- (2013) K. Klein et al. JOURNAL OF VIROLOGY
- Immune clearance of highly pathogenic SIV infection
- (2013) Scott G. Hansen et al. NATURE
- Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
- (2013) Hua-Xin Liao et al. NATURE
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms
- (2013) S. G. Hansen et al. SCIENCE
- Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
- (2013) J. Jardine et al. SCIENCE
- Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site
- (2013) Ivelin S. Georgiev et al. Current Opinion in HIV and AIDS
- Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
- (2013) Sam Hoot et al. PLoS Pathogens
- Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
- (2013) Jean-Philippe Julien et al. PLoS Pathogens
- A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
- (2013) Rogier W. Sanders et al. PLoS Pathogens
- Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)
- (2012) A. Duerr et al. JOURNAL OF INFECTIOUS DISEASES
- Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144
- (2012) Merlin L Robb et al. LANCET INFECTIOUS DISEASES
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Prophylaxis for HIV Infection among African Women
- (2012) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control
- (2012) Beatriz Mothe et al. PLoS One
- Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
- (2012) B. Moldt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
- (2011) Nicole Frahm et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
- (2011) Glenda E Gray et al. LANCET INFECTIOUS DISEASES
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
- (2011) D. R. Burton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
- (2011) Iliyana Mikell et al. PLoS Pathogens
- Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
- (2010) Dan H Barouch et al. NATURE MEDICINE
- Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
- (2010) Sampa Santra et al. NATURE MEDICINE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
- (2010) Q. Abdool Karim et al. SCIENCE
- Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression
- (2009) Marit J van Gils et al. AIDS
- Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
- (2009) Xiaodong Xiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L
- (2009) A. J. Hessell et al. JOURNAL OF VIROLOGY
- Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
- (2009) N. A. Doria-Rose et al. JOURNAL OF VIROLOGY
- Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
- (2009) M. D. Simek et al. JOURNAL OF VIROLOGY
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1
- (2009) Avishek Nandi et al. VIROLOGY
- Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
- (2009) Ann J. Hessell et al. PLoS Pathogens
- Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults
- (2008) Frances H. Priddy et al. CLINICAL INFECTIOUS DISEASES
- Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
- (2008) D. N. Sather et al. JOURNAL OF VIROLOGY
- Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
- (2008) J. M. Binley et al. JOURNAL OF VIROLOGY
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now